{"id":"https://openalex.org/W2807448447","doi":null,"title":"Glutaredoxin-1 As A Therapeutic Target In Neurodegenerative Inflammation","display_name":"Glutaredoxin-1 As A Therapeutic Target In Neurodegenerative Inflammation","publication_year":2017,"publication_date":"2017-01-01","ids":{"openalex":"https://openalex.org/W2807448447","mag":"2807448447"},"language":"en","primary_location":{"id":"pmh:oai:etd.ohiolink.edu:case1493307283210551","doi":null,"is_oa":true,"landing_page_url":"http://rave.ohiolink.edu/etdc/view?acc_num=case1493307283210551","pdf_url":"http://rave.ohiolink.edu/etdc/view?acc_num=case1493307283210551","source":{"id":"https://openalex.org/S4377196344","display_name":"OhioLink ETD Center (Ohio Library and Information Network)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210155183","host_organization_name":"Ohio Library and Information Network","host_organization_lineage":["https://openalex.org/I4210155183"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://rave.ohiolink.edu/etdc/view?acc_num=case1493307283210551","raw_type":"text"},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://rave.ohiolink.edu/etdc/view?acc_num=case1493307283210551","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067898296","display_name":"Olga Gorelenkova Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Olga Gorelenkova Miller","raw_affiliation_strings":["Case Western Reserve University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Western Reserve University","institution_ids":["https://openalex.org/I58956616"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5067898296"],"corresponding_institution_ids":["https://openalex.org/I58956616"],"apc_list":null,"apc_paid":null,"fwci":0.1365,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.56562271,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.9320999979972839,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.9320999979972839,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.051500000059604645,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11884","display_name":"Redox biology and oxidative stress","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glutaredoxin-1","display_name":"glutaredoxin 1","score":0.9850000143051147},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.7789999842643738},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.921999990940094},{"id":"https://openalex.org/keywords/microglial-activation","display_name":"microglial activation","score":0.8799999952316284},{"id":"https://openalex.org/keywords/dopaminergic-neurons","display_name":"dopaminergic neurons","score":0.7269999980926514},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.5899999737739563},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.5920000076293945},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9470000267028809},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.699999988079071},{"id":"https://openalex.org/keywords/nf-kappab","display_name":"NF-\u03baB","score":0.6990000009536743},{"id":"https://openalex.org/keywords/nurr1","display_name":"Nurr1","score":0.949999988079071},{"id":"https://openalex.org/keywords/ap-1","display_name":"AP-1","score":0.9089999794960022},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.9010000228881836},{"id":"https://openalex.org/keywords/glutathionylation","display_name":"glutathionylation","score":0.7480000257492065},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.6019999980926514},{"id":"https://openalex.org/keywords/gene-copy-number","display_name":"gene copy number","score":0.5619999766349792},{"id":"https://openalex.org/keywords/neuronal-death","display_name":"neuronal cell death","score":0.6330000162124634},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.335999995470047}],"concepts":[{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.6708997488021851},{"id":"https://openalex.org/C125619963","wikidata":"https://www.wikidata.org/wiki/Q81984039","display_name":"Glutaredoxin","level":4,"score":0.4165892004966736},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4069344997406006},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.34389734268188477},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22602114081382751},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.18885108828544617},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18131065368652344},{"id":"https://openalex.org/C3623737","wikidata":"https://www.wikidata.org/wiki/Q421219","display_name":"Thioredoxin","level":3,"score":0.0947255790233612}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:etd.ohiolink.edu:case1493307283210551","doi":null,"is_oa":true,"landing_page_url":"http://rave.ohiolink.edu/etdc/view?acc_num=case1493307283210551","pdf_url":"http://rave.ohiolink.edu/etdc/view?acc_num=case1493307283210551","source":{"id":"https://openalex.org/S4377196344","display_name":"OhioLink ETD Center (Ohio Library and Information Network)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210155183","host_organization_name":"Ohio Library and Information Network","host_organization_lineage":["https://openalex.org/I4210155183"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://rave.ohiolink.edu/etdc/view?acc_num=case1493307283210551","raw_type":"text"},{"id":"mag:2807448447","doi":null,"is_oa":false,"landing_page_url":"http://rave.ohiolink.edu/etdc/view?acc_num=case1493307283210551","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:etd.ohiolink.edu:case1493307283210551","doi":null,"is_oa":true,"landing_page_url":"http://rave.ohiolink.edu/etdc/view?acc_num=case1493307283210551","pdf_url":"http://rave.ohiolink.edu/etdc/view?acc_num=case1493307283210551","source":{"id":"https://openalex.org/S4377196344","display_name":"OhioLink ETD Center (Ohio Library and Information Network)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210155183","host_organization_name":"Ohio Library and Information Network","host_organization_lineage":["https://openalex.org/I4210155183"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://rave.ohiolink.edu/etdc/view?acc_num=case1493307283210551","raw_type":"text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.4699999988079071}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2807448447.pdf","grobid_xml":"https://content.openalex.org/works/W2807448447.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2406777542","https://openalex.org/W2769820080","https://openalex.org/W2045465918","https://openalex.org/W3038602168","https://openalex.org/W2121896871","https://openalex.org/W7096257441","https://openalex.org/W2093272411","https://openalex.org/W3010873992","https://openalex.org/W2277886163","https://openalex.org/W1587360940"],"abstract_inverted_index":{"Introduction":[0,679],"61":[1],"2.3":[2],"Results":[3],"63":[4,19],"2.3.1":[5],"Increase":[6],"in":[7,24,29,36,42,49,66,77,93,116,134,179,259,272,295,329,369,450,463,473,492,509,515,550,563,581,602,611,640,657,685,690,747,756,761,842,859,875,882],"GLRX":[8],"copy":[9],"number":[10,225],"is":[11,53,235,360,375,393,420,458,527,557,590,703,780,797,823],"associated":[12,733],"with":[13,287,506,734],"earlier":[14],"age":[15],"of":[16,80,96,101,111,121,156,164,208,269,311,323,334,365,379,400,467,476,495,499,512,537,548,553,573,587,630,638,644,661,681,711,737,745,784,786,816,840,851,857,865],"PD":[17,108,135,291,392,441,457,464,477,481,514,524,712,738,773,886],"onset":[18,136,331],"2.3.2Inflammatory":[20],"agents":[21,483,518],"induce":[22],"Grx1":[23,47,64,103,112,133,184,257,270,277,285,294,324,556,594,617,639,655,669,858,874],"microglia":[25,30,37,160],"65":[26],"2.3.3Grx1":[27],"levels":[28],"govern":[31],"activation":[32,95],"69":[33],"2.3.4Grx1":[34],"upregulation":[35,89,271,656],"promotes":[38,73],"neuronal":[39,75,412,490],"cell":[40,565,582,787,793],"death":[41],"co--culture":[43],"71":[44],"2.3.5":[45],"Microglial":[46],"induction":[48,104,278,325],"response":[50,600],"to":[51,289,411,487,597,726,799],"LPS":[52],"regulated":[54,798],"by":[55,353,405,559,803],"the":[56,254,266,305,312,321,330,370,376,383,407,451,474,510,598,635,645,682,743,748,757,824,846,849,855,862],"AP--1,":[57],"NF\u03baB":[58],"/":[59],"Nurr1":[60],"axis":[61],"76":[62],"2.3.6":[63],"overexpression":[65,185],"vivo":[67],"displays":[68],"a":[69,78,340,361,397,421,507,528,545,551,570,607,623,651,667,704,770,781,800,837],"pro--inflammatory":[70,94,267,578,636],"phenotype":[71],"and":[72,105,113,141,148,173,193,248,332,385,437,480,584,604,622,649,672,678,695,717,763,774,791,795,831,885,887],"DA":[74,489],"loss":[76,491],"model":[79],"metabolic":[81],"syndrome":[82],"81":[83],"2.4":[84],"Discussion":[85,247],"84":[86,99],"2.4.1":[87],"Glutaredoxin":[88],"--a":[90],"common":[91],"factor":[92],"immune":[97],"cells":[98,181],"2.4.2Mechanism":[100],"microglial":[102,860],"implications":[106],"for":[107,131,302,391,440,456,523,625,654,827,848,873,891],"85":[109],"2.4.3Interrelationship":[110],"TNF--\u03b1":[114],"--role":[115],"inflammation":[117,549,554,716,746,841,876,884],"86":[118],"2.4.4Exacerbating":[119],"effect":[120,268],"insulin":[122],"resistance":[123],"on":[124,615,665,854],"dopaminergic":[125,366],"viability":[126],"88":[127],"2.4.5":[128],"Genetic":[129],"evidence":[130,872],"elevated":[132],"91":[137],"v":[138],"2.5":[139],"Materials":[140],"Methods":[142],"94":[143,146,151],"2.5.1":[144],"Reagents":[145],"2.5.2Animals":[147],"animal":[149,478,493,585],"tissue":[150,191],"2.5.3Immunohistochemistry":[152],"95":[153,161],"2.5.4":[154],"Isolation":[155,163],"mouse":[157],"primary":[158,166],"neonatal":[159],"2.5.5":[162],"rat":[165],"embryonic":[167],"neurons":[168,368],"96":[169,175],"2.5.6":[170],"Cell":[171],"lines":[172],"treatments":[174,455],"2.5.7":[176],"RNA":[177],"silencing":[178,576],"BV2":[180],"97":[182,186,188],"2.5.8Adenoviral":[183],"2.5.9Co--culture":[187],"2.5.10":[189],"Brain":[190],"homogenization":[192],"analysis":[194,222,227],"98":[195],"2.5.11Chromatin":[196],"immunoprecipitation":[197],"(ChIP)":[198],"99":[199,203],"2.5.12Glutaredoxin":[200],"activity":[201],"assay":[202],"2.5.13ELISA":[204],"100":[205,212,214,216],"2.5.14":[206],"Determination":[207],"glutathionylated":[209],"protein":[210,829],"content":[211],"2.5.15RT--qPCR":[213],"2.5.16Immunoprecipitation":[215],"2.5.17Western":[217],"blotting":[218],"101":[219,223],"2.5.18Gene":[220],"expression":[221],"2.5.19Copy":[224],"variant":[226],"102":[228],"Chapter":[229,245,686],"3:":[230],"Novel":[231],"Chloroacetamido":[232],"Compound":[233],"CWR--J02":[234],"an":[236,426,444,520,619],"Anti--Inflammatory":[237],"Glutaredoxin--1":[238,344],"Inhibitor":[239],"vi":[240],"103":[241,244],"3.1":[242],"Abstract":[243,352],"4:":[246,698],"Significance":[249,310],"147":[250],"4.1":[251],"What":[252],"are":[253,433],"factors":[255],"regulating":[256,828],"transcription":[258],"microglia?147":[260],"4.2":[261],"Which":[262],"S--glutathionylatable":[263],"proteins":[264,818],"mediate":[265,820],"microglia?149":[273],"4.3":[274],"How":[275,283],"can":[276],"promote":[279,290],"PD?":[280],"151":[281],"4.4":[282],"does":[284,415],"synergize":[286],"HFHS/T2D":[288],"onset?158":[292],"4.5":[293],"astrocytes":[296],"162":[297],"4.6":[298],"Predicting":[299],"therapeutic":[300,608],"uses":[301],"J02":[303],"outside":[304],"anti--inflammatory":[306,517,626,674],"realm":[307],"165":[308],"4.7":[309],"work":[313,683],"169Chapter":[314],"5:":[315],"Future":[316],"Directions":[317],"172":[318,337],"5.1":[319],"Determining":[320],"role":[322,637,653,744,881],"versus":[326],"diminution":[327],"viii":[328],"progression":[333],"Parkinson's":[335,357,700],"disease":[336,358,403,418,701],"5.2":[338],"Designing":[339],"Grx1--targeted":[341],"inhibitor":[342],"1":[343,430,687],"As":[345],"A":[346],"Therapeutic":[347],"Target":[348],"In":[349],"Neurodegenerative":[350],"Inflammation":[351],"OLGA":[354],"GORELENKOVA":[355],"MILLER":[356],"(PD)":[359,702],"debilitating":[362,705],"movement":[363,706],"disorder.Degeneration":[364],"(DA)":[367],"substantia":[371],"nigra":[372],"pars":[373],"compacta":[374],"main":[377,389],"feature":[378],"PD.PD":[380],"primarily":[381],"affects":[382],"elderly,":[384],"it":[386,796,832],".is":[387],"incurable.The":[388],"treatment":[390],"Levodopa":[394],"(L--DOPA,":[395],"L--3,4--dihydroxyphenylalanine),":[396],"brain-permeable":[398],"precursor":[399],"dopamine,":[401],"alleviates":[402],"symptoms":[404],"replenishing":[406],"neurotransmitter":[408],"lost":[409],"due":[410],"degeneration.However,":[413],"L--DOPA":[414],"not":[416],"block":[417],"progression.PD":[419],"social":[422],"as":[423,425,544,618,723,753,755,836],"well":[424,754],"economic":[427],"burden.Currently,":[428],"over":[429],"million":[431],"Americans":[432],"suffering":[434],"from":[435],"PD,":[436,603,762],"medical":[438],"care":[439],"patients":[442],"costs":[443],"estimated":[445],"$23":[446],"billion":[447],"per":[448],"year":[449],"US.Therefore,":[452],"developing":[453,513,892],"better":[454],"paramount.Inflammation":[459],"has":[460,503,541,713,731,833],"been":[461,471,485,504,542,714,721,732,834],"implicated":[462,543,722,835],"etiology.Increased":[465],"concentrations":[466],"inflammatory":[468,561,574,588,599,620,766,789,817],"cytokines":[469],"have":[470,484,720],"detected":[472],"midbrain":[475],"models":[479,494,586],"patients.Anti--inflammatory":[482],"found":[486],"decrease":[488,508],"PD.Moreover,":[496],"increased":[497,735],"use":[498],"non--steroidal":[500],"anti--inflammatories":[501],"(NSAIDs)":[502],"correlated":[505],"probability":[511],"humans.Therefore,":[516],"represent":[519,606],"attractive":[521],"avenue":[522],"treatment.Glutaredoxin--1":[525],"(Grx1)":[526,822],"ubiquitously":[529],"expressed":[530],"oxidoreductase":[531],"enzyme":[532,825],"that":[533,593,877],"specifically":[534],"catalyzes":[535],"reduction":[536],"glutathionyl":[538],"mixed":[539],"disulfides.Grx1":[540],"positive":[546,838],"regulator":[547,839],"variety":[552],"models.Moreover,":[555],"upregulated":[558],"various":[560],"stimuli":[562],"distinct":[564],"types,":[566],"thereby":[567],"potentially":[568],"creating":[569],"feed--forward":[571],"loop":[572],"propagation.Grx1":[575],"inhibits":[577],"cytokine":[579],"release":[580],"culture":[583],"disease.It":[589],"therefore":[591],"plausible":[592],"contributes":[595],"importantly":[596],"observed":[601],"could":[605],"target.Research":[609],"presented":[610,684],"this":[612,631,662,807,852,866],"thesis":[613,632,663,853],"focuses":[614,664],"examining":[616],"mediator":[621],"target":[624],"therapy.The":[627],"first":[628],"part":[629,660,802],"research":[633],"documents":[634],"microglia,":[641],"resident":[642],"macrophages":[643],"central":[646,749],"nervous":[647,750,759],"system;":[648],"discovers":[650],"deleterious":[652],"PD.The":[658],"second":[659],"characterizing":[666],"novel":[668],"inhibitor,":[670],"CWR--J02,":[671],"its":[673,727,879],"properties.Chapter":[675],"1:":[676],"Background":[677],"Part":[680],"was":[688],"published":[689],"Arch":[691],"Toxicol":[692],"89(9):":[693],"1439--1467":[694],"Macrophage":[696],"2017;":[697],"e1504":[699],"disorder.While":[707],"no":[708],"single":[709],"cause":[710],"elucidated,":[715],"redox":[718],"imbalance":[719],"important":[724],"contributors":[725],"etiology.Diabetes":[728],"mellitus":[729,776],"(DM)":[730],"risk":[736],"development.This":[739],"introductory":[740,867],"section":[741],"describes":[742],"system":[751,760],"(CNS)":[752],"peripheral":[758],"considers":[764],"how":[765,811],"responses":[767],"may":[768,819],"provide":[769],"connection":[771],"between":[772],"Diabetes":[775],"(DM).Redox":[777],"signal":[778],"transduction":[779],"key":[782],"mechanism":[783],"control":[785],"survival,":[788],"responses,":[790],"programmed":[792],"death,":[794],"large":[801],"reversible":[804],"cysteine":[805,812],"modifications.In":[806],"section,":[808],"I":[809,869],"describe":[810,889],"modifications,":[813],"including":[814],"S-glutathionylation,":[815],"inflammation.Glutaredoxin--1":[821],"responsible":[826],"glutathionylation,":[830],"several":[843],"contexts,":[844],"providing":[845],"premise":[847],"focus":[850],"function":[856],"cells.In":[861],"concluding":[863],"portion":[864],"chapter,":[868],"review":[870],"previous":[871],"forecast":[878],"potential":[880],"CNS":[883],"then":[888],"strategies":[890],"inhibitors":[893]},"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-09-16T18:09:00.828671","created_date":"2018-06-13T00:00:00"}